These results indicate that both single and fractionated injection of [212Pb]VMT01 monotherapy efficiently attenuated MC1R-postive melanoma tumor, but only single injection of [212Pb]VMT01 induced an immune response that led to complete tumor regression in combination with ICIs. The gene discussed is MC1R; the disease is neoplasm.